Literature DB >> 6934003

Absorption of methotrexate under standardized conditions in children with acute lymphoblastic leukaemia.

C R Pinkerton, S G Welshman, S I Dempsey, J M Bridges, J F Glasgow.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6934003      PMCID： PMC2010450          DOI： 10.1038/bjc.1980.286

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  5 in total

1.  Morphologic alterations induced by methotrexate in the mucosa of human proximal intestine. I. Serial observations by light microscopy.

Authors:  J S TRIER
Journal:  Gastroenterology       Date:  1962-03       Impact factor: 22.682

2.  Effect of methotrexate on drug absorption from the rat small intestine in situ and in vitro.

Authors:  V M Venho
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1976-05

Review 3.  Present understanding of the interaction of drugs and food during absorption.

Authors:  A Krondl
Journal:  Can Med Assoc J       Date:  1970-08-15       Impact factor: 8.262

4.  Radioimmunoassayable methotrexate concentrations in plasma and skin exudate of patients with psoriasis.

Authors:  K Boomla; G W Aherne; M W Greaves; M Quinton
Journal:  Clin Exp Dermatol       Date:  1979-12       Impact factor: 3.470

5.  Unpredictable serum levels after oral methotrexate in children with acute lymphoblastic leukaemia.

Authors:  P J Kearney; P A Light; A Preece; M G Mott
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333
  5 in total
  11 in total

Review 1.  Clinical pharmacokinetics of methotrexate in children.

Authors:  Y M Wang; T Fujimoto
Journal:  Clin Pharmacokinet       Date:  1984 Jul-Aug       Impact factor: 6.447

2.  Jejunal crypt cell abnormalities associated with methotrexate treatment in children with acute lymphoblastic leukaemia.

Authors:  C R Pinkerton; C H Cameron; J M Sloan; J F Glasgow; N J Gwevava
Journal:  J Clin Pathol       Date:  1982-11       Impact factor: 3.411

3.  Small bowel enterocyte abnormalities caused by methotrexate treatment in acute lymphoblastic leukaemia of childhood.

Authors:  N J Gwavava; C R Pinkerton; J F Glasgow; J M Sloan; J M Bridges
Journal:  J Clin Pathol       Date:  1981-07       Impact factor: 3.411

4.  Pharmacokinetics of oral and intramuscular methotrexate in children with acute lymphoblastic leukaemia.

Authors:  A D Pearson; S Mills; H A Amineddine; D R Long; A W Craft; J M Chessells
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

5.  Pharmacokinetics of methotrexate and 7-hydroxy-methotrexate in plasma and bone marrow of children receiving low-dose oral methotrexate.

Authors:  P Sonneveld; F W Schultz; K Nooter; K Hählen
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

6.  Topical methotrexate alters solute and water transport in the rat jejunum in vivo and rabbit ileum in vitro.

Authors:  C R Pinkerton; I W Booth; P J Milla
Journal:  Gut       Date:  1985-07       Impact factor: 23.059

7.  Small intestinal transit time affects methotrexate absorption in children with acute lymphoblastic leukemia.

Authors:  A D Pearson; A W Craft; E J Eastham; G W Aherne; P Littleton; G L Pearson; A N Campbell
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

8.  Pharmacokinetics of low-dose methotrexate in children receiving maintenance therapy for acute lymphoblastic leukaemia.

Authors:  C R Pinkerton; S G Welshman; J G Kelly; R G Shanks; J M Bridges
Journal:  Cancer Chemother Pharmacol       Date:  1982-12       Impact factor: 3.333

9.  The influence of serum methotrexate concentrations and drug dosage on outcome in childhood acute lymphoblastic leukaemia.

Authors:  A D Pearson; H A Amineddine; M Yule; S Mills; D R Long; A W Craft; J M Chessells
Journal:  Br J Cancer       Date:  1991-07       Impact factor: 7.640

10.  Physiologically based pharmacokinetic modelling of methotrexate and 6-mercaptopurine in adults and children. Part 1: methotrexate.

Authors:  Kayode Ogungbenro; Leon Aarons
Journal:  J Pharmacokinet Pharmacodyn       Date:  2014-03-21       Impact factor: 2.745
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.